Literature DB >> 8471541

Determination of dihydrocodeine in hair of opiate addicts by GC/MS.

H Sachs1, R Denk, I Raff.   

Abstract

After the examination of more than 300 hair samples of suspected heroin abusers, a large number of which proved positive, we can say that high concentrations of dihydrocodeine can be determined either in addition to, or in the place of, morphine and also frequently in combination with codeine. The opiates were extracted after dissolving the hair samples in NaOH and hydrolysis with HCl. The quantitative determination of dihydrocodeine was achieved by derivatisation with HFBA using GC/MS at m/u = 497. Dihydrocodeine is used in antitussive drugs. After the examination of individual hair samples, it was obvious that some heroin consumers had switched to dihydrocodeine. This may lead to the conclusion that dihydrocodeine itself is used either as an intoxicating drug or to reduce withdrawal symptoms. The increasing number of positive samples should be noted by the legal authorities.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8471541     DOI: 10.1007/bf01370380

Source DB:  PubMed          Journal:  Int J Legal Med        ISSN: 0937-9827            Impact factor:   2.686


  4 in total

1.  [The detection of codeine abuse by hair analysis].

Authors:  M Scheller; H Sachs
Journal:  Dtsch Med Wochenschr       Date:  1990-08-31       Impact factor: 0.628

2.  Results of comparative determination of morphine in human hair using RIA and GC/MS.

Authors:  H Sachs; W Arnold
Journal:  J Clin Chem Clin Biochem       Date:  1989-11

3.  [Gas chromatography-mass spectrometry findings of morphine and codeine in the vitreous humor and hair].

Authors:  H Sachs; H Brunner
Journal:  Beitr Gerichtl Med       Date:  1986

4.  [Determination of morphine in human hair (author's transl)].

Authors:  E Klug
Journal:  Z Rechtsmed       Date:  1980
  4 in total
  1 in total

1.  Characterization of dextromoramide (Palfium) abuse by hair analysis in a denied case.

Authors:  P Kintz; V Cirimele; Y Edel; A Tracqui; P Mangin
Journal:  Int J Legal Med       Date:  1995       Impact factor: 2.686

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.